TickerFacts.

Krystal Biotech, Inc. (KRYS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$141.14M
Year ended 2022-12-31
2019-12-31: -$20.99M2020-12-31: -$31.15M2021-12-31: -$65.51M2022-12-31: -$141.14M-$141.14M
2019-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$141.14Mn/m2025-02-19, From 2022-01-01
2021-12-31-$65.51Mn/m2024-02-26, From 2021-01-01
2020-12-31-$31.15Mn/m2023-02-27, From 2020-01-01
2019-12-31-$20.99Mn/a2021-03-01, From 2019-01-01